...
机译:谁的胰岛素抵抗性更高,IFG人群或IGT人群?
Diabetes Center (formerly the Insulin Resistance Research Group) Tokyo Women’s Medical UniversitySaitama-ken Saiseikai Kurihashi Hospital;
Diabetes Center (formerly the Insulin Resistance Research Group) Tokyo Women’s Medical University;
Diabetes Center (formerly the Insulin Resistance Research Group) Tokyo Women’s Medical University;
Diabetes Center (formerly the Insulin Resistance Research Group) Tokyo Women’s Medical University;
Diabetes Center (formerly the Insulin Resistance Research Group) Tokyo Women’s Medical University;
Diabetes Center (formerly the Insulin Resistance Research Group) Tokyo Women’s Medical University;
Saitama-ken Saiseikai Kurihashi Hospital;
Saitama-ken Saiseikai Kurihashi Hospital;
机译:患有IFG和IGT的韩国受试者的胰岛素抵抗和胰岛素分泌能力特征。
机译:通过口服葡萄糖耐量试验评估胰岛素释放和胰岛素敏感性:NGT,IFG,IGT和2型糖尿病之间的差异。横断面和后续研究。
机译:用胰岛素抗性2型糖尿病患者控制餐后高血糖的胰岛素Aspart与胰岛素Aspart进行蛋白质胰岛素
机译:肥胖和超重人民的生活方式防御机制及相关性状
机译:中国草药治疗葡萄糖耐量损害和胰岛素抵抗力的人
机译:进餐时速效门冬胰岛素和门冬胰岛素可控制胰岛素抵抗性2型糖尿病患者的餐后高血糖
机译:谁更具胰岛素抵抗力,IFG或IGT的人的人?